10
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Features and Outcome of Pneumocystis carinii Pneumonia According to Risk Category for HIV Infection

, , &
Pages 57-61 | Received 16 Sep 1996, Accepted 15 Nov 1996, Published online: 08 Jul 2009

References

  • Centres for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for people infected with HIV. JAMA 1989; 262: 335–339
  • Kovacs J A, Masur H. Prophylaxis of Pneumocystis carinii pneumonia: an update. J Infect Dis 1989; 160: 882–886
  • O'Donnell A E, Selig J, Aravamuthan M, Richardson M SA. Pulmonary complications associated with illicit drug use – an update. Chest 1995; 108: 460–463
  • Brettle R P, Gore S M, McNeil A. Outpatient medical care of injection drug use related HIV. Int J STD AIDS 1992; 3: 96–100
  • Hopewell P C. Pneumocystis carinii pneumonia: Diagnosis. J Infect Dis 1988; 157: 1115–1119
  • Brenner M, Ognibene F P, Lack E E, Simmons J T, Suffredini A F, Lane H C, Fauci A S, Parrillo J E, Shelhamer J H, Masur H. Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Resp Dis 1987; 136: 1199–1206
  • Antinori A, Maiuro G, Pallavicini F, Ventura G, Marasca G, Murri R, Pizzigallo E, Camilli G, Tamburrini E. Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome. Eur J Epidemiol 1993; 9: 183–189
  • Kales C P, Murren J R, Torres R A, Crocco J A. Early predictors of in-hospital mortality for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med 1987; 147: 1413–1417
  • Sepkowitz K A, Telzak E E, Gold J WM, Bernard E M, Blum S, Carrow M, Dickmeyer M, Armstrong D. Pneumothorax in AIDS. Ann Intern Med 1991; 114: 455–459
  • Broaddus C, Drake M D, Stulburg M S, Blumenfeld W, Hadley W K, Golden J A, Hopewell P C. Broncoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infection in the acquired immunodeficiency syndrome. Ann Intern Med 1986; 102: 747–752
  • Elvin K. Laboratory diagnosis and occurrence of Pneumocystis carinii. Scand J Infect Dis Suppl 1994; 94: 1–34
  • Leigh T R, Kirby K, Gazzard B G, Collins J V. Effect of sputum induction on arterial oxygen saturation and spirometry in HIV-infected patients. Eur Resp J 1994; 7: 435–438
  • Willocks L, Cowan F, Brettle R P, Emmanuel P J, Burns S. The spectrum of chest infections in HIV-positive patients in Edinburgh. J Infect 1992; 24: 37–42
  • Lundgren J D, Barton S E, Katlama C, Ledregerber B, Gonzalez-Lahoz J, Pinching A J, Proenca R, Hemmer R, Pedersen C. Phillips AN for the multicentre study group on AIDS in Europe. Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with Acquired Immunodeficiency Syndrome. Arch Intern Med 1995; 155: 822–828
  • Lemp G F, Payne S F, Neal D, Temelso T, Rutherford G W. Survival trends for patients with AIDS. JAMA 1990; 263: 402–406
  • Fischl M A, Richmann D D, Grieco M H, Gottlieb M S, Volberding P A, Laskin O L, Leedom J M, Groopman J E, Mildvan D, Schooley R T, Jackson G G, Durack D T, King D, AZT collaborative working group. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double blind, placebo-controlled trial. N Engl J Med 1987; 317: 185–191, and the

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.